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Background
VRC01 and related antibodies target the CD4 binding site
(CD4bs), are broadly neutralizing and highly potent, and
have undergone high levels of somatic hypermutation. To
optimize such antibodies for passive immunization and to
further understand antibody development, we reverted
three CD4bs antibodies towards their putative germlines
and analyzed the effects on breadth and potency. Interest-
ingly, we also identified key germline reversion mutations
that increased neutralization potential.
Methods
Structure/function-based analyses were used to design
partially reverted heavy and light chains based on the clon-
ally-related antibodies VRC01, NIH45-46, and VRC07.
Mature CDRs were maintained and framework regions
were back-mutated. The antibodies were expressed, puri-
fied, and tested for binding to gp120 by ELISA. Neutraliza-
tion against a panel of tier 2 HIV-1 pseudotyped viruses
was determined for select antibodies.
Results
The heavy chains of VRC01, NIH45-46, and VRC07 are
42%, 41%, and 44% somatically mutated from their germ-
line precursor, while the light chains are 29% (VRC01/07)
and 27% (NIH45-46) somatically mutated. We began by
reverting over half of the heavy chain somatic mutations
and over one-third of the light chain somatic mutations to
their germline residue identities. An iterative design
approach was used, and we systematically re-introduced
mature residues to the partial germline reversions. Most
mutants retained the ability to bind gp120 and neutralize
diverse HIV-1 pseudoviruses, albeit with lower breadth
and/or potency than their mature counterparts.
Additionally, we found 3 partial-germline reversion muta-
tions that increased VRC07 potency.
Conclusion
Here, we showed that in most cases mature framework
regions in addition to mature CDRs were required for
highest neutralization potency and breadth. However,
three framework germline reversion mutations increased
potency 2-3 fold. These partial reversions are being
combined with other mutations, including those that
modulate Fc effector function, to optimize the antibody
function for passive transfer in NHPs and humans.
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